» Articles » PMID: 32980319

Extrapulmonary Manifestations of COVID-19 in Children: a Comprehensive Review and Pathophysiological Considerations

Overview
Specialty Pediatrics
Date 2020 Sep 27
PMID 32980319
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The aim of this review was to summarize the most common extrapulmonary manifestations in pediatric patients with COVID-19, as well as to discuss clinical, epidemiological, and pathophysiological aspects of these clinical presentations in children.

Source Of Data: An extensive search of literature was performed in order to identify pediatric cases with extrapulmonary manifestations between January 1, 2020 and June 21, 2020. Generic keywords, such as "Novel coronavirus" or "Novel coronavirus 2019" or "2019 nCoV" or "COVID-19" or "SARS-CoV-2" were searched on PubMed database, associated either with age filters or generic pediatric terms.

Summary Of Findings: A total of 28 articles, including 199 patients, were considered suitable to review and data extraction. The main findings were summarized in tables. The main non-pulmonary manifestations in pediatric patients, in decreasing order of frequency, were gastrointestinal, renal, cardiovascular, neurological, hematological and lymphatic, cutaneous, hepatic, ocular, olfactory, and gustatory. Multisystem impairment and Kawasaki-like disease were also described.

Conclusions: Differences in immune response of children and variations of tissue expression of angiotensin converting enzyme 2, the virus receptor, are likely to influence clinical, epidemiological, and pathophysiological patterns of the disease.

Citing Articles

COVID-19 and Cardiac Implications-Still a Mystery in Clinical Practice.

Borka Balas R, Melit L, Marginean C Rev Cardiovasc Med. 2024; 24(5):125.

PMID: 39076755 PMC: 11273018. DOI: 10.31083/j.rcm2405125.


Description of COVID-19 outbreaks in childcare facilities in Alberta, March 2020 to December 31, 2021.

Geary J, Rudko S, Scott A Can Commun Dis Rep. 2024; 49(4):113-126.

PMID: 38361646 PMC: 10869177. DOI: 10.14745/ccdr.v49i04a04.


Evaluation of various blood biomarkers associated with the outcomes of patients with COVID‑19 treated in intensive care units.

Genc S, Taghizadehghalehjoughi A, Naldan M, Gulcu O, Caglayan C, Spanakis M Exp Ther Med. 2024; 27(2):82.

PMID: 38274343 PMC: 10809360. DOI: 10.3892/etm.2024.12371.


Ascending aortic pseudoaneurysm presenting as heart failure in a child - A rare complication associated with coronavirus disease 2019.

Bakhru S, Dhulipudi B, Koneti N Ann Pediatr Cardiol. 2023; 16(2):118-121.

PMID: 37767162 PMC: 10522150. DOI: 10.4103/apc.apc_28_23.


Rapid Triage of Children with Suspected COVID-19 Using Laboratory-Based Machine-Learning Algorithms.

Dobrijevic D, Vilotijevic-Dautovic G, Katanic J, Horvat M, Horvat Z, Pastor K Viruses. 2023; 15(7).

PMID: 37515208 PMC: 10383367. DOI: 10.3390/v15071522.


References
1.
Li J, Lam D, Chen Y, Ting D . Novel Coronavirus disease 2019 (COVID-19): The importance of recognising possible early ocular manifestation and using protective eyewear. Br J Ophthalmol. 2020; 104(3):297-298. DOI: 10.1136/bjophthalmol-2020-315994. View

2.
Sundel R . Kawasaki disease. Rheum Dis Clin North Am. 2014; 41(1):63-73, viii. DOI: 10.1016/j.rdc.2014.09.010. View

3.
Holappa M, Vapaatalo H, Vaajanen A . Many Faces of Renin-angiotensin System - Focus on Eye. Open Ophthalmol J. 2017; 11:122-142. PMC: 5510558. DOI: 10.2174/1874364101711010122. View

4.
Rowley A, Baker S, Orenstein J, Shulman S . Searching for the cause of Kawasaki disease--cytoplasmic inclusion bodies provide new insight. Nat Rev Microbiol. 2008; 6(5):394-401. PMC: 7097362. DOI: 10.1038/nrmicro1853. View

5.
Dodi I, Castellone E, Pappalardo M, Rubini M, Veronese P, Ruberto C . SARS-CoV-2 infection in children in Parma. Acta Biomed. 2020; 91(2):214-215. PMC: 7569611. DOI: 10.23750/abm.v91i2.9563. View